Panaxia Labs Cash Per Share vs. EBITDA
| HROD Stock | 5,700 448.00 8.53% |
For Panaxia Labs profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Panaxia Labs to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Panaxia Labs Israel utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Panaxia Labs's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Panaxia Labs Israel over time as well as its relative position and ranking within its peers.
Panaxia |
Panaxia Labs Israel EBITDA vs. Cash Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Panaxia Labs's current stock value. Our valuation model uses many indicators to compare Panaxia Labs value to that of its competitors to determine the firm's financial worth. Panaxia Labs Israel is one of the top stocks in cash per share category among its peers. It also is one of the top stocks in ebitda category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Panaxia Labs by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Panaxia Labs' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Panaxia EBITDA vs. Cash Per Share
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Panaxia Labs |
| = | 0.83 X |
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Panaxia Labs |
| = | (15.07 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Panaxia EBITDA Comparison
Panaxia Labs is currently under evaluation in ebitda category among its peers.
Panaxia Labs Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Panaxia Labs, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Panaxia Labs will eventually generate negative long term returns. The profitability progress is the general direction of Panaxia Labs' change in net profit over the period of time. It can combine multiple indicators of Panaxia Labs, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Panaxia Pharmaceutical Industries Ltd provides pharmaceutical solutions for patients and physicians. The company was incorporated in 2016 and is based in Lod, Israel. HERODIUM INVEST is traded on Tel Aviv Stock Exchange in Israel.
Panaxia Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Panaxia Labs. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Panaxia Labs position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Panaxia Labs' important profitability drivers and their relationship over time.
Use Panaxia Labs in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Panaxia Labs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Panaxia Labs will appreciate offsetting losses from the drop in the long position's value.Panaxia Labs Pair Trading
Panaxia Labs Israel Pair Trading Analysis
The ability to find closely correlated positions to Panaxia Labs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Panaxia Labs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Panaxia Labs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Panaxia Labs Israel to buy it.
The correlation of Panaxia Labs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Panaxia Labs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Panaxia Labs Israel moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Panaxia Labs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Panaxia Labs position
In addition to having Panaxia Labs in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sovereign ETFs Thematic Idea Now
Sovereign ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Sovereign ETFs theme has 17 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sovereign ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Panaxia Stock
To fully project Panaxia Labs' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Panaxia Labs Israel at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Panaxia Labs' income statement, its balance sheet, and the statement of cash flows.